New Research Questions Whether Vitamin D, Fish Oil and Glucosamine Help or Hurt Aging Brains

Three separate studies published in 2026 are raising uncomfortable questions about some of the most commonly used supplements in America, according to reporting by The Washington Post on September 10, 2026.

In January, researchers reported an association between vitamin D supplement use and faster cognitive decline among older adults who already had normal vitamin D blood levels, per the Post's reporting. In April, a separate study found adults 55 and older taking omega-3 fish oil supplements showed greater cognitive deterioration over time than nonusers. Then in June, researchers reported that people taking glucosamine, a joint-pain supplement, had a much higher likelihood of progressing from mild cognitive impairment to full dementia over five years than peers who skipped it.

"I was stunned," Ramon Sun, a professor of biochemistry and molecular biology at the University of Florida and lead author of the glucosamine paper, told the Post.

Correlation, Not Proof

Here's the catch: all three studies are observational. They show a statistical association, not a mechanism, and they contradict other research in places, according to the Post's reporting. Researchers themselves say the findings are preliminary and far from proof that any of these supplements cause brain decline.

That distinction matters, and it got lost fast. Three outlets, Archynewsy, News Directory 3, and Archyde, ran nearly identical writeups of the same Washington Post reporting within days of each other, none adding independent data or new sourcing. That's republication, not three separate confirmations.

The vitamin D finding in particular drew pushback. A commentator posting under the name Karl on X argued the study doesn't hold up to scrutiny, a critique highlighted by the newsletter rapamycin.news alongside the underlying paper published in BMJ Open. Karl's specific objections weren't detailed beyond the screenshot cited, but the broader point, that this vitamin D study alone shouldn't drive anyone's supplement decisions, is one even researchers pushing the findings would likely concede given how preliminary the data is.

Why Aging Changes the Math

The theory researchers are chasing: aging changes how the brain handles fats, calcium and glucose, and how it responds to inflammation, according to the Post. That could alter how nutrients and drugs reach brain tissue in ways that simply don't show up in younger, healthier people. Archyde's reporting adds a physiological detail here worth noting, that the blood-brain barrier becomes more permeable with age, and that high concentrations of antioxidants or metal ions could theoretically flip from protective to harmful through oxidative stress, a mechanism still under study rather than established fact.

Older adults also metabolize substances differently than younger people. Age-related changes in liver and kidney function can cause active ingredients to linger longer in the bloodstream, and polypharmacy, taking multiple medications at once, raises the odds of an unexpected interaction, according to the Post's reporting.

The Regulatory Gap, Both Sides

Under the Dietary Supplement Health and Education Act of 1994, the FDA classifies supplements as foods, not drugs, meaning manufacturers don't have to prove safety or efficacy before products hit shelves, according to Archyde's reporting. Critics see that as a hole in oversight that leaves millions of consumers as unwitting test subjects for years before problems surface.

There's a fair counterpoint. DSHEA exists because Americans wanted the freedom to buy vitamins, minerals and herbal products without a bureaucratic pre-approval process every time a new formulation hits the market, the same argument that underlies broad opposition to expanding federal regulatory reach into everyday consumer choices. Nobody needs a permission slip from Washington to buy calcium or fish oil. The tradeoff is that post-market surveillance, the kind producing these three 2026 studies, becomes the primary way problems get caught, and that surveillance runs years or decades behind adoption.

Lithium Cuts the Other Way

Not every trace substance fits a simple good-or-bad story. Lithium, present naturally in groundwater and foods like leafy greens and chickpeas, has decades of use as a bipolar disorder treatment and is increasingly described by some physicians as an essential nutrient, according to The Epoch Times. Aimie Apigian, a physician who says lithium supplementation stabilized her own anxiety and burnout after therapy and medication failed, told the Epoch Times the mineral "took the edge off, made things much more manageable."

But groundwater lithium levels vary enormously by location, from under 2.3 micrograms per liter in parts of Florida and Massachusetts to over 149 micrograms per liter in West Texas and parts of Arizona, per the Epoch Times. And separate research cited by the same outlet has linked high lithium levels in drinking water to a substantially increased autism risk, a finding that complicates any simple case that more of a naturally occurring mineral is automatically better.

No federal dietary requirement exists for lithium intake, and none of the sources here identify a comparable large-scale, long-term randomized trial for any of these substances, vitamin D, omega-3, glucosamine, or lithium, in aging populations specifically. That's the open question researchers themselves are now racing to answer: whether what looks safe, or even beneficial, at 40 still looks that way at 75.